ipilimumab, nivolumab & brentuximab vedotin for r/r hodgkin lymphoma
Published 5 years ago • 232 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
1:08
nivolumab and brentuximab vedotin with or without bendamustine for r/r hodgkin lymphoma
-
1:24
novel agents for the treatment of hodgkin lymphoma: brentuximab vedotin and nivolumab
-
2:50
nivolumab and allogeneic transplantation in r/r classical hodgkin lymphoma
-
1:14
brentuximab vedotin combined with nivolumab for hodgkin lymphoma
-
6:45
brentuximab vedotin with nivolumab ± ipilimumab in r/r hl: outcomes with and without autosct
-
1:41
swog s1826: nivolumab avd vs brentuximab vedotin avd for advanced stage hodgkin lymphoma
-
3:23
brentuximab vedotin, nivolumab, doxorubicin & dacarbazine for early stage classical hodgkin lymphoma
-
1:59
updates on the use of nivolumab in hodgkin lymphoma & how this agent may impact treatment
-
14:42
impact of echelon-1 on the future of treatment
-
1:01:08
bispecific antibodies in lymphoma
-
1:00:50
hodgkin's lymphoma
-
3:53
e4412 update: ipi-nivo-brentuximab for r/r hodgkin lymphoma
-
2:36
brentuximab vedotin versus pembrolizumab in r/r classical hodgkin lymphoma
-
3:24
results from the breselibet trial of brentuximab vedotin chemotherapy for r/r hodgkin lymphoma
-
3:21
brentuximab vedotin nivolumab in lymphoma
-
4:22
brentuximab vedotin-nivolumab alone and then with r-chp as frontline therapy for pmbcl
-
1:27
treatment options for patients with hodgkin lymphoma who progress after brentuximab vedotin
-
1:04
updates on the use of brentuximab vedotin in later-stage hl
-
1:14
pd-l1 inhibitors in r/r hodgkin lymphoma
-
1:25
results of checkmate 039 trial of nivolumab in combination with ipilimumab for hodgkin lymphoma
-
1:30
advances in the management of r/r hodgkin lymphoma
-
2:18
sgn35-027: brentuximab vedotin with nivolumab, doxorubicin, and dacarbazine in hl